Unlisted shares of Senores Pharmaceuticals Ltd are currently trading at Rs 611 in the grey market, reflecting a premium of Rs ...

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

The Senores Pharmaceuticals’ public issue will close for public bidding on December 24. The IPO has received 1.78x ...

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December ...

Ahead of the IPO, Senores Pharmaceuticals on Thursday, 19 December 2024, raised Rs 260.62 crore from anchor investors. The board allotted 66.65 lakh shares at Rs 391 each to 20 anchor investors.

Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Senores Pharmaceuticals Ltd. opened for day two of subscription on Monday. The Rs 582.11-crore offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.11 crore. It has been ...

Senores Pharmaceuticals IPO comprises a fresh issue of shares worth Rs 500 crore and an offer-for-sale (OFS) of up to ...

Amid the ongoing flurry of IPOs, three issues- Ventive Hospitality, Senores Pharmaceuticals and Carraro India- which opened ...

The Initial Public Offering of Senores Pharmaceuticals Limited was fully subscribed on the first day of bidding.

Five IPOs closed today with robust oversubscription, led by Mamata Machinery (195 times) and DAM Capital Advisors (82 times). Four IPOs remain open, reflecting strong year-end investor interest.

The week will witness the launch of one mainboard IPO and two SME IPOs, keeping Dalal Street abuzz. Additionally, eight ...